메뉴 건너뛰기




Volumn 140, Issue 1, 2014, Pages 77-82

Olanzapine is effective for refractory chemotherapy-induced nausea and vomiting irrespective of chemotherapy emetogenicity

Author keywords

Cancer treatment; Chemotherapy induced nausea and vomiting; Nausea; Olanzapine; Supportive care; Vomiting

Indexed keywords

ANTINEOPLASTIC AGENT; APREPITANT; BENZODIAZEPINE DERIVATIVE; CORTICOSTEROID; DOPAMINE RECEPTOR BLOCKING AGENT; OLANZAPINE; SEROTONIN ANTAGONIST;

EID: 84892671186     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-013-1540-z     Document Type: Article
Times cited : (26)

References (33)
  • 1
    • 0020687971 scopus 로고
    • Metoclopramide: Pharmacology and clinical application
    • Albibi R, McCallum RW (1983) Metoclopramide: pharmacology and clinical application. Ann Intern Med 98:86-95 (Pubitemid 13217970)
    • (1983) Annals of Internal Medicine , vol.98 , Issue.1 , pp. 86-95
    • Albibi, R.1    McCallum, R.W.2
  • 2
    • 0035041926 scopus 로고    scopus 로고
    • Antipsychotic-induced weight gain: A review of the literature
    • Allison DB, Casey DE (2001) Antipsychotic-induced weight gain: a review of the literature. J Clin Psychiatry 62:22-31 (Pubitemid 32402182)
    • (2001) Journal of Clinical Psychiatry , vol.62 , Issue.SUPPL. 7 , pp. 22-31
    • Allison, D.B.1    Casey, D.E.2
  • 3
    • 0020576099 scopus 로고
    • Clinical pharmacokinetics of metoclopramide
    • Bateman DN (1983) Clinical pharmacokinetics of metoclopramide. Clin Pharmacokinet 8:523-529 (Pubitemid 13023845)
    • (1983) Clinical Pharmacokinetics , vol.8 , Issue.6 , pp. 523-529
    • Bateman, D.N.1
  • 6
    • 0025615002 scopus 로고
    • Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study
    • 2146911 10.7326/0003-4819-113-11-834
    • De Mulder PH, Seynaeve C, Vermorken JB, van Liessum PA, Mols-Jevdevic S, Allman EL, Beranek P, Verweij J (1990) Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study. Ann Intern Med 113:834-840
    • (1990) Ann Intern Med , vol.113 , pp. 834-840
    • De Mulder, P.H.1    Seynaeve, C.2    Vermorken, J.B.3    Van Liessum, P.A.4    Mols-Jevdevic, S.5    Allman, E.L.6    Beranek, P.7    Verweij, J.8
  • 9
  • 10
    • 34547872714 scopus 로고    scopus 로고
    • Anti-emetic therapy in cancer chemotherapy: Current status
    • DOI 10.1111/j.1742-7843.2007.00122.x
    • Herrstedt J, Dombernowsky P (2007) Anti-emetic therapy in cancer chemotherapy: current status. Basic Clin Pharmacol Toxicol 101:143-150 (Pubitemid 47256390)
    • (2007) Basic and Clinical Pharmacology and Toxicology , vol.101 , Issue.3 , pp. 143-150
    • Herrstedt, J.1    Dombernowsky, P.2
  • 11
    • 44849134443 scopus 로고    scopus 로고
    • Chemotherapy-induced nausea and vomiting
    • DOI 10.1056/NEJMra0706547
    • Hesketh PJ (2008) Chemotherapy-induced nausea and vomiting. N Engl J Med 358:2482-2494 (Pubitemid 351793021)
    • (2008) New England Journal of Medicine , vol.358 , Issue.23
    • Hesketh, P.J.1
  • 12
    • 0038372531 scopus 로고    scopus 로고
    • Olanzapine for intractable nausea in palliative care patients
    • Jackson WC, Tavernier L (2003) Olanzapine for intractable nausea in palliative care patients. J Palliat Med 6:251-255 (Pubitemid 36538899)
    • (2003) Journal of Palliative Medicine , vol.6 , Issue.2 , pp. 251-255
    • Jackson, W.C.1    Tavernier, L.2
  • 13
    • 84869228161 scopus 로고    scopus 로고
    • Olanzapine for the relief of nausea in patients with advanced cancer and incomplete bowel obstruction
    • 1:CAS:528:DC%2BC38XpvFCrsbg%3D 10.1016/j.jpainsymman.2011.10.023
    • Kaneishi K, Kawabata M, Morita T (2012) Olanzapine for the relief of nausea in patients with advanced cancer and incomplete bowel obstruction. J Pain Symptom Manag 44:604-607
    • (2012) J Pain Symptom Manag , vol.44 , pp. 604-607
    • Kaneishi, K.1    Kawabata, M.2    Morita, T.3
  • 14
    • 34250810912 scopus 로고    scopus 로고
    • Cancer chemotherapy and cachexia: Mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects
    • 1:STN:280:DC%2BD2szntFyhtw%3D%3D 10.1111/j.1365-2354.2006.00760.x
    • Kast RE, Foley KF (2007) Cancer chemotherapy and cachexia: mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects. Eur J Cancer Care 16:351-354
    • (2007) Eur J Cancer Care , vol.16 , pp. 351-354
    • Kast, R.E.1    Foley, K.F.2
  • 15
    • 0022412283 scopus 로고
    • Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: Improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone
    • Kris MG, Gralla RJ, Clark RA, Tyson LB, Fiore JJ, Kelsen DP, Groshen S (1985) Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone. Cancer Treat Rep 69:1257-1262 (Pubitemid 16217005)
    • (1985) Cancer Treatment Reports , vol.69 , Issue.11 , pp. 1257-1262
    • Kris, M.G.1    Gralla, R.J.2    Clark, R.A.3
  • 18
    • 34347369980 scopus 로고    scopus 로고
    • A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: A Hoosier oncology group study
    • DOI 10.1007/s00520-007-0248-5
    • Navari RM, Einhorn LH, Loehrer PJ Sr, Passik SD, Vinson J, McClean J, Chowhan N, Hanna NH, Johnson CS (2007) A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study. Support Care Cancer 15:1285-1291 (Pubitemid 47583449)
    • (2007) Supportive Care in Cancer , vol.15 , Issue.11 , pp. 1285-1291
    • Navari, R.M.1    Einhorn, L.H.2    Loehrer Sr., P.J.3    Passik, S.D.4    Vinson, J.5    McClean, J.6    Chowhan, N.7    Hanna, N.H.8    Johnson, C.S.9
  • 19
    • 82855171513 scopus 로고    scopus 로고
    • Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: A randomized phase III trial
    • 1:CAS:528:DC%2BC3MXhsVWjsLbP 22024310 10.1016/j.suponc.2011.05.002
    • Navari RM, Gray SE, Kerr AC (2011) Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a randomized phase III trial. J Support Oncol 9:188-195
    • (2011) J Support Oncol , vol.9 , pp. 188-195
    • Navari, R.M.1    Gray, S.E.2    Kerr, A.C.3
  • 20
    • 84879149213 scopus 로고    scopus 로고
    • The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy
    • 23314603 10.1007/s00520-012-1710-6
    • Navari RM, Nagy CK, Gray SE (2013) The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy. Support Care Cancer 21:1655-1663
    • (2013) Support Care Cancer , vol.21 , pp. 1655-1663
    • Navari, R.M.1    Nagy, C.K.2    Gray, S.E.3
  • 21
    • 0036286412 scopus 로고    scopus 로고
    • A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain
    • DOI 10.1016/S0885-3924(02)00391-3, PII S0885392402003913
    • Passik SD, Lundberg J, Kirsh KL, Theobald D, Donaghy K, Holtsclaw E, Cooper M, Dugan W (2002) A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain. J Pain Symptom Manag 23:526-532 (Pubitemid 34627037)
    • (2002) Journal of Pain and Symptom Management , vol.23 , Issue.6 , pp. 526-532
    • Passik, S.D.1    Lundberg, J.2    Kirsh, K.L.3    Theobald, D.4    Donaghy, K.5    Holtsclaw, E.6    Cooper, M.7    Dugan, W.8
  • 23
    • 4744339480 scopus 로고    scopus 로고
    • A phase I trial of olanzapine (zyprexa) for the prevention of delayed emesis in cancer patients: A hoosier oncology group study
    • DOI 10.1081/CNV-200029066
    • Passik SD, Navari RM, Jung SH, Nagy C, Vinson J, Kirsh KL, Loehrer P (2004) A phase I trial of olanzapine (Zyprexa) for the prevention of delayed emesis in cancer patients: a hoosier oncology group study. Cancer Invest 22:383-388 (Pubitemid 39310908)
    • (2004) Cancer Investigation , vol.22 , Issue.3 , pp. 383-388
    • Passik, S.D.1    Navari, R.M.2    Jung, S.-H.3    Nagy, C.4    Vinson, J.5    Kirsh, K.L.6    Loehrer, P.7
  • 24
    • 0033135007 scopus 로고    scopus 로고
    • A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis
    • DOI 10.1016/S0002-9270(98)00337-2, PII S0002927098003372
    • Patterson D, Abell T, Rothstein R, Koch K, Barnett J (1999) A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis. Am J Gastroenterol 94:1230-1234 (Pubitemid 29214634)
    • (1999) American Journal of Gastroenterology , vol.94 , Issue.5 , pp. 1230-1234
    • Patterson, D.1    Abell, T.2    Rothstein, R.3    Koch, K.4    Barnett, J.5
  • 25
    • 0033974902 scopus 로고    scopus 로고
    • Remission of chemotherapy-induced emesis with concurrent olanzapine treatment: A case report
    • DOI 10.1002/(SICI)1099-1611(200001/02)9:1<84::AID-PON440>3.0.CO;2-T
    • Pirl WF, Roth AJ (2000) Remission of chemotherapy-induced emesis with concurrent olanzapine treatment: a case report. Psychooncology 9:84-87 (Pubitemid 30110394)
    • (2000) Psycho-Oncology , vol.9 , Issue.1 , pp. 84-87
    • Pirl, W.F.1    Roth, A.J.2
  • 26
    • 0025881104 scopus 로고
    • Predictive factors of delayed emesis in cisplatin-treated patients and antiemetic activity and tolerability of metoclopramide or dexamethasone. A randomized single-blind study
    • 1:STN:280:DyaK3M3jtl2msQ%3D%3D 2031511 10.1097/00000421-199106000-00010
    • Roila F, Boschetti E, Tonato M, Basurto C, Bracarda S, Picciafuoco M, Patoia L, Santi E, Penza O, Ballatori E, et al. (1991) Predictive factors of delayed emesis in cisplatin-treated patients and antiemetic activity and tolerability of metoclopramide or dexamethasone. A randomized single-blind study. Am J Clin Oncol 14:238-242
    • (1991) Am J Clin Oncol , vol.14 , pp. 238-242
    • Roila, F.1    Boschetti, E.2    Tonato, M.3    Basurto, C.4    Bracarda, S.5    Picciafuoco, M.6    Patoia, L.7    Santi, E.8    Penza, O.9    Ballatori, E.10
  • 27
    • 79960435777 scopus 로고    scopus 로고
    • Chemotherapy-induced nausea and vomiting and antiemetic prophylaxis with palonosetron versus other 5-HT3 receptor antagonists in patients with cancer treated with low emetogenic chemotherapy in a hospital outpatient setting in the United States
    • 1:CAS:528:DC%2BC3MXovFKmtbY%3D 21696263 10.1185/03007995.2011.596201
    • Schwartzberg L, Morrow G, Balu S, Craver C, Gayle J, Cox D (2011) Chemotherapy-induced nausea and vomiting and antiemetic prophylaxis with palonosetron versus other 5-HT3 receptor antagonists in patients with cancer treated with low emetogenic chemotherapy in a hospital outpatient setting in the United States. Curr Med Res Opin 27:1613-1622
    • (2011) Curr Med Res Opin , vol.27 , pp. 1613-1622
    • Schwartzberg, L.1    Morrow, G.2    Balu, S.3    Craver, C.4    Gayle, J.5    Cox, D.6
  • 28
    • 33645396238 scopus 로고    scopus 로고
    • Olanzapine use in cancer patients for refractory vomiting
    • 1:CAS:528:DC%2BD28XjtFWktb4%3D 16531716
    • Shinjo T, Okada M (2006) Olanzapine use in cancer patients for refractory vomiting. Gan To Kagaku Ryoho 33:349-352
    • (2006) Gan to Kagaku Ryoho , vol.33 , pp. 349-352
    • Shinjo, T.1    Okada, M.2
  • 29
    • 0026443746 scopus 로고
    • Phase III double-blind comparison of intravenous ondansetron and metoclopramide as antiemetic therapy for patients receiving multiple-day cisplatin-based chemotherapy
    • 1423181 10.1002/1097-0142(19921115)70:10<2524: AID- CNCR2820701022>3.0.CO;2-Z
    • Sledge GW Jr, Einhorn L, Nagy C, House K (1992) Phase III double-blind comparison of intravenous ondansetron and metoclopramide as antiemetic therapy for patients receiving multiple-day cisplatin-based chemotherapy. Cancer 70:2524-2528
    • (1992) Cancer , vol.70 , pp. 2524-2528
    • Sledge, Jr.G.W.1    Einhorn, L.2    Nagy, C.3    House, K.4
  • 31
    • 0021359406 scopus 로고
    • Intravenous metoclopramide: Prevention of chemotherapy-induced nausea and vomiting. A preliminary evaluation
    • Strum SB, McDermed JE, Pileggi J, Riech LP, Whitaker H (1984) Intravenous metoclopramide: prevention of chemotherapy-induced nausea and vomiting. A preliminary evaluation. Cancer 53:1432-1439 (Pubitemid 14198909)
    • (1984) Cancer , vol.53 , Issue.6 , pp. 1432-1439
    • Strum, S.B.1    McDermed, J.E.2    Pileggi, J.3
  • 33
    • 79953317123 scopus 로고    scopus 로고
    • Clinical research of olanzapine for prevention of chemotherapy-induced nausea and vomiting
    • 19775450 10.1186/1756-9966-28-131
    • Tan L, Liu J, Liu X, Chen J, Yan Z, Yang H, Zhang D (2009) Clinical research of olanzapine for prevention of chemotherapy-induced nausea and vomiting. J Exp Clin Cancer Res 28:131
    • (2009) J Exp Clin Cancer Res , vol.28 , pp. 131
    • Tan, L.1    Liu, J.2    Liu, X.3    Chen, J.4    Yan, Z.5    Yang, H.6    Zhang, D.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.